VentriPoint Diagnostics Ltd V.VPT

Financials anyone? Cash runway?

[GrahamB]

 

Just working through the financials , and calculating liquidity and cash burn

Would love to have others insights so I can learn
 

I am here because I heard about the company on another board, and put in the work to learn so I benefit in my growth as an investor continuing to analyze, since there aren’t any analysts following and it’s a chance to work through the financials 
 

So...

If Net cash used in operating activities 1,974,232 from cash flow statement over last 6 months the monthly cash burn rate is approximately $329,039.

Cash and cash equivalents $305,615 from June 30,2024

So, the cash will last for approximately 0.93 months, or roughly 28 days, if there is no further revenue so in August -how could they operate?

 

Going back to the financing update on July 2,2024 :” further to Ventripoint’s press release dated May 13, 2024 announcing the closing of the first tranche of the previously announced non-brokered private placement (the “Offering”) of unsecured debentures (“Debentures”) which raised gross proceeds of $941,000, Ventripoint is pleased to announce it has closed the second tranche of the Offering with gross proceeds of $184,000.

In total, Ventripoint raised an aggregate of $1,125,000 pursuant to both tranches of the Offering.”

 

2024-07-02 | Ventripoint Announces Closing of Second Tranche of Non-Brokered Convertible Debenture Private Placement and the Extension of the Offering | TSXV:VPT | Press Release

 

So how much of this was included or not?

On June 30 financials 1,004,457 was the net cash that included the 1,125,000 Issuance of convertible debentures

So I would think that unless any sales came in or additional revenue that the well is dry or almost dry without the financing ?

 

Any thoughts apredicated 

 

This is for entertainment and education-mine mostly 

Do your own due diligence.

Talk to your financial advisor which I as, not and dont trust my advice, nor anyone on a stock 

[GrahamB]

 Additional relevant notes on the liquidity situation form sedar:"The Company  had a negative working capital of $1,149,698  at  June 30, 2024  (December 31, 2023  – positive working capital of $240,094).  Based on the rate of expenditure, the Company does not have sufficient cash on hand and will have to raise equity

[Pandora]

From the Ascend presentation: Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients. Ventripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels

[GrahamB]

Interesting, but if they do not have cash, and they cannot close this financing how can they continue to promote and try to get any sales? This financing has been open and still could not fill and now they are going to retail investors. In the most recent financials, this is what they say, in addition to the numbers, I have posted.  There is no certainty whether the Company will generate

[Pandora]

The "signifcant doubt about their ability to continue as a going concern" is placed by probably 50% of thousands of companies -- most of which do not have the inroads that Ventripoint apparently has. i.e. it's pretty much standard phrase or language for financials in their 'accompanying notes'. At this stage of where we are at, I am not too concerned about the language

[GrahamB]

If you could provide a reference, that 50% of companies have a going concern, indicating that there is a material uncertainty, I would appreciate it. I am unaware of any such numbers.   To the point, I posted numbers, From the company, which actually do support material uncertainty, Which also supports the statement that the company has stated. in which the cash burn, is at the worst less

[Pandora]

Back in the day when Sedar was a simple easy application for Dummies I can recall many, many standard statements in the financials quoting words to that effect. I am not about to try and chase up stats for your satisfaction. You just come on here to be a ---- disturber and for no other purpose. You quote all the numbers that satisfy your arguments and have some fool like me or JoJo react so you

[GrahamB]

  Pandora, the point is, that many around here, throw out statements that are unsupported, and misleading to many. Stating that over 50% or that most companies have a going concern statement is simply not true. I asked for a reference because I already know the number. It's usually in the single digits, but I can creep up, in times of economic uncertainty. I can provide a reference-but

[PlasticOno]

GrahamB, what in your opinion are the reasons why up to this date there are hardly andy sales and revenue in spite of a promising product that is easyier to handle and significantly reducing costs for clinics?

[GrahamB]

  I can tell you my thoughts, but they’re just my thoughts, and again I’m just using this as an exercise at this point to try to understand an analyze a small cap to see if I can get it right, but really I’m trying to spend more time in stocks that at this point, I think I’m going to invest in. There’s not a lot of point in spending time here I’ve kind of come to the conclusion that this

[PlasticOno]

thanks

[G1945V]

My 2 cents: They developed a promising product, with cMRI level accuracy. It's having problems with creating widespread awareness. The medical field creatures of habit, is hanging on to the old ways and won't rush to adapt to new ways, sticking with what they know best for now, old school mentality. Building a brand takes time and money. VMS+ would reduce costs but the initial investment

[jopatclo]

see 0.185$ green in red market today game on TSX-V see GranhambWalk no shares le vautour FUDSTER manipulateur attention is triste personnage V:VPT - VentriPoint Diagnostics Ltd. - https://www.ventripoint.com 15:54:00 EDT Sym-X Offre - Demande Dernier Chg %Ch Vol $Vol #Tr Ouvert-Hi

[riverrrow]

From my very limited understanding of the VMS products, it seems to me that the new product, VMS+4, is the truly marketable version.  We may be talking Windows 11 compared to earlier versions which would be Windows 3.1.